PETER HIATT

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address6701 FANNIN
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. De Boeck K, Walker S, Faro A, Hiatt P, Gilmartin G, Higgins M, Munck A. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J Cyst Fibros. 2014 Dec; 13(6):674-80. PMID: 25266159.
      Citations: 121     Fields:    Translation:HumansCells
    2. Luna RA, Millecker LA, Webb CR, Mason SK, Whaley EM, Starke JR, Hiatt PW, Versalovic J. Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. J Clin Microbiol. 2013 Apr; 51(4):1237-40. PMID: 23303498; PMCID: PMC3666811.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    3. Brumback LC, Davis SD, Kerby GS, Kloster M, Johnson R, Castile R, Hiatt PW, Hart M, Rosenfeld M. Lung function from infancy to preschool in a cohort of children with cystic fibrosis. Eur Respir J. 2013 Jan; 41(1):60-6. PMID: 22653767.
      Citations: 3     Fields:    Translation:Humans
    4. Kerby GS, Rosenfeld M, Ren CL, Mayer OH, Brumback L, Castile R, Hart MA, Hiatt P, Kloster M, Johnson R, Jones P, Davis SD. Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatr Pulmonol. 2012 Jun; 47(6):597-605. PMID: 22081559.
      Citations: 10     Fields:    Translation:Humans
    5. Ren CL, Rosenfeld M, Mayer OH, Davis SD, Kloster M, Castile RG, Hiatt PW, Hart M, Johnson R, Jones P, Brumback LC, Kerby GS. Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun; 47(6):574-81. PMID: 22081584.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    6. Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J, Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, Rosenfeld M, Ramsey BW, Early Pseudomonas Infection Control (EPIC) Investigators, Treggiari MM. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med. 2011 Sep; 165(9):847-56. PMID: 21893650; PMCID: PMC3991697.
      Citations: 68     Fields:    Translation:HumansCells
    7. Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD, Colin AA, Conrad CK, Hart MA, Hiatt PW, Mogayzel PJ, Johnson RC, Wilcox SL, Castile RG, Davis SD. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med. 2010 Dec 01; 182(11):1387-97. PMID: 20622043; PMCID: PMC3159081.
      Citations: 23     Fields:    Translation:Humans
    8. Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Williams J, Ramsey BW. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol. 2007 Jul; 42(7):610-23. PMID: 17534969.
      Citations: 27     Fields:    Translation:Humans
    9. Garcia DF, Hiatt PW, Jewell A, Schoonover SL, Cron SG, Riggs M, Grace S, Oermann CM, Piedra PA. Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatr Pulmonol. 2007 Jan; 42(1):66-74. PMID: 17123316.
      Citations: 15     Fields:    Translation:HumansCells
    10. Koumbourlis AC, Chen XC, Rao JS, Schluchter MD, Easley K, Colin AA, Hiatt P, Kattan M, McCarthy K, Mellins RB, Peavy H, Platzker AC, Steinbach S, Ting A, Weisner MD, Wohl ME, Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodificienc, National Heart, Lung and Blood Institute. Maximal expiratory flow at FRC (V'maxFRC): Methods of selection and differences in reported values. Pediatr Pulmonol. 2004 Apr; 37(4):318-23. PMID: 15022128; PMCID: PMC4410185.
      Citations:    Fields:    Translation:Humans
    11. Ernst RK, D'Argenio DA, Ichikawa JK, Bangera MG, Selgrade S, Burns JL, Hiatt P, McCoy K, Brittnacher M, Kas A, Spencer DH, Olson MV, Ramsey BW, Lory S, Miller SI. Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol. 2003 Dec; 5(12):1341-9. PMID: 14641578.
      Citations: 46     Fields:    Translation:HumansCells
    12. Piedra PA, Cron SG, Jewell A, Hamblett N, McBride R, Palacio MA, Ginsberg R, Oermann CM, Hiatt PW, Purified Fusion Protein Vaccine Study Group. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60. PMID: 12744878.
      Citations: 35     Fields:    Translation:HumansCellsCTClinical Trials
    13. Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B, Cystic Fibrosis Therapeutics Development Network Study Group. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med. 2003 Mar 15; 167(6):841-9. PMID: 12480612.
      Citations: 88     Fields:    Translation:HumansCellsCTClinical Trials
    HIATT's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (108)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _